70
Participants
Start Date
November 3, 2024
Primary Completion Date
July 31, 2025
Study Completion Date
August 31, 2025
The daily ingestion of capsules containing naringenin
Following surgical intervention, patients will be administered two capsules (equivalent to 500 mg) daily for a period of 14 days. Subsequently, patients will ingest the maintenance dose of 250 mg per day until the 90th day post-surgery.
Placebo
The daily ingestion of capsules containing placebo
RECRUITING
Ayatollah Taleghani Educational Hospital, Tehran
Shahid Beheshti University of Medical Sciences
OTHER